Medical insurance price of bimetinib/bemetinib in 2026

The original drug Bimetinib/Binimetinib has not yet been launched in the Chinese market, nor has it been included in domestic medical insurance. As a targeted drug targeting BRAF mutations, bimetinib has a significant effect in the treatment of malignant tumors such as melanoma, especially when used in combination with Encorafenib. Its therapeutic effect is particularly outstanding for patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations. However, since the drug has not yet been officially launched in China, patients can only obtain it through imported channels, and this process is often accompanied by higher prices.

In some countries and regions, especially in the United States and Europe, bimetinib is often more expensive. For example, in the United States, a single regimen of bimetinib can cost thousands of dollars, and that doesn't include the cost of combining it with encofenib. The cost of treatment for patients may vary based on different drug strengths and treatment regimen needs.

Although bimetinib is not currently included in domestic medical insurance, as the domestic demand for targeted therapy drugs increases, there may be policy adjustments in the future, especially in terms of drug prices and medical insurance reimbursement. If bimetinib is included in medical insurance, patients' treatment burden may be significantly reduced, and the availability and popularity of the drug will be greatly improved. At present, when purchasing bimetinib, patients should pay attention to the source, price and legal channels of the drug to ensure the safety and effectiveness of the treatment.

In the long term, with the continuous development of biopharmaceutical technology and the gradual improvement of domestic medical insurance policies, targeted drugs like bimetinib are expected to gradually enter the medical insurance system, further reducing patients' economic burden and providing more treatment options. In order to obtain more precise treatment as early as possible, patients can learn about the price and purchase method of bimetinib from the hospital or drug supplier, and discuss the most suitable treatment plan with the doctor.

Reference materials:https://en.wikipedia.org/wiki/Binimetinib